NEW YORK (GenomeWeb News) — Beckman Coulter today said fourth-quarter revenues increased 8.6 percent as R&D spending receded 2.7 percent and profit jumped 250 percent.
Total receipts for the three months ended Dec. 31, 2006, increased to $712 million from $655.5 million year over year.
Product-related revenue increased 8.1 percent to $104 million while service-related revenue was up 8.7 percent to $608 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.